Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)

AIMS: An association between antibody deficiency and clozapine use in individuals with schizophrenia has recently been reported. We hypothesised that if clozapine-associated hypogammaglobulinaemia was clinically relevant this would manifest in referral patterns. METHODS: Retrospective case note revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponsford, Mark James, Steven, Rachael, Bramhall, Kathyrn, Burgess, Mathew, Wijetilleka, Sonali, Carne, Emily, McGuire, Frances, Price, Colin R, Moody, Mo, Zouwail, Soha, Tahir, Tayyeb, Farewell, Daniel, El-Shanawany, Tariq, Jolles, Stephen R A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476264/
https://www.ncbi.nlm.nih.gov/pubmed/32094276
http://dx.doi.org/10.1136/jclinpath-2019-206235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476264/
https://www.ncbi.nlm.nih.gov/pubmed/32094276
http://dx.doi.org/10.1136/jclinpath-2019-206235

Ejemplares similares